Clinical Trials Browser

Phase 1/2 × NSCLC × Antigens × Clear all

NCT04199559 2019-12-16

Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer

Phase 1/2 Unknown

NSCLC